Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Skyhawk Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Skyhawk Therapeutics

Skyhawk Therapeutics

Skyhawk Therapeutics: Developing small molecule therapeutics for cancer and neurological diseases.

HQ
Waltham, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Skyhawk Therapeutics, founded in Massachusetts, is dedicated to developing small molecule therapeutics aimed at treating cancer and neurological diseases. The company leverages its proprietary SKYSTAR® platform to create novel RNA-targeting small molecules, addressing some of the world's most challenging medical conditions. Skyhawk's mission is to revolutionize treatment options across neurology, oncology, and fibrosis, making significant strides in the pharmaceutical industry.

Notable affiliations include collaborations with leading pharmaceutical companies such as Bristol-Myers Squibb (BMS), Biogen, Genentech, Ipsen, Merck, Takeda, and Vertex. These partnerships have been instrumental in advancing Skyhawk's research and development efforts. Key achievements include the successful development of their unique platform and the initiation of multiple therapeutic programs. Skyhawk Therapeutics has made a substantial impact by pushing the boundaries of RNA-targeted therapies, offering new hope for patients with intractable diseases.

Skyhawk Therapeutics - Similar Companies

Arrakis Therapeutics logo

Arrakis Therapeutics

arrakistx.com

Skylark Bio logo

Skylark Bio

skylarkbio.com

Meadowhawk Biolabs logo

Meadowhawk Biolabs

Star Therapeutics logo

Star Therapeutics

NightHawk Biosciences logo

NightHawk Biosciences

ReviR Therapeutics logo

ReviR Therapeutics

revirtx.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Expansion Therapeutics logo

Expansion Therapeutics

expansionrx.com

858 Therapeutics logo

858 Therapeutics

8five8tx.com

SphynKx Therapeutics logo

SphynKx Therapeutics

SpringWorks Therapeutics logo

SpringWorks Therapeutics

springworkstx.com

Scholar Rock Holding logo

Scholar Rock Holding

scholarrock.com

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

BlossomHill Therapeutics logo

BlossomHill Therapeutics

bhtherapeutics.com

Synnovation Therapeutics logo

Synnovation Therapeutics

synnovationtx.com

Skyhawk Therapeutics - Quick Facts

Who are Skyhawk Therapeutics' competitors?

Companies similar to Skyhawk Therapeutics include Arrakis Therapeutics, Skylark Bio, Meadowhawk Biolabs and Star Therapeutics.

When was Skyhawk Therapeutics founded?

Skyhawk Therapeutics was founded in 2016.

Where is Skyhawk Therapeutics' headquarters located?

Skyhawk Therapeutics' headquarters is located in Waltham, MA, US.

When was Skyhawk Therapeutics' last funding round?

Skyhawk Therapeutics' most recent funding round was for $133M (USD) in September 2021.

How much has Skyhawk Therapeutics raised to-date?

As of Sep 14, 2021, Skyhawk Therapeutics has raised a total of $181.2M (USD).

How many employees does Skyhawk Therapeutics have?

Skyhawk Therapeutics has 64 employees as of Feb 4, 2024.

Skyhawk Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified